Literature DB >> 19158424

Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.

Marjo H Eskelinen1, Tiia Ngandu, Jaakko Tuomilehto, Hilkka Soininen, Miia Kivipelto.   

Abstract

Caffeine stimulates central nervous system on a short term. However, the long-term impact of caffeine on cognition remains unclear. We aimed to study the association between coffee and/or tea consumption at midlife and dementia/Alzheimer's disease (AD) risk in late-life. Participants of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study were randomly selected from the survivors of a population-based cohorts previously surveyed within the North Karelia Project and the FINMONICA study in 1972, 1977, 1982 or 1987 (midlife visit). After an average follow-up of 21 years, 1409 individuals (71%) aged 65 to 79 completed the re-examination in 1998. A total of 61 cases were identified as demented (48 with AD). Coffee drinkers at midlife had lower risk of dementia and AD later in life compared with those drinking no or only little coffee adjusted for demographic, lifestyle and vascular factors, apolipoprotein E epsilon4 allele and depressive symptoms. The lowest risk (65% decreased) was found in people who drank 3-5 cups per day. Tea drinking was relatively uncommon and was not associated with dementia/AD. Coffee drinking at midlife is associated with a decreased risk of dementia/AD later in life. This finding might open possibilities for prevention of dementia/AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158424     DOI: 10.3233/JAD-2009-0920

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  112 in total

Review 1.  Tea and cognitive health in late life: current evidence and future directions.

Authors:  J Song; H Xu; F Liu; L Feng
Journal:  J Nutr Health Aging       Date:  2012-01       Impact factor: 4.075

Review 2.  Current therapeutic targets for the treatment of Alzheimer's disease.

Authors:  Joshua D Grill; Jeffrey L Cummings
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

3.  Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.

Authors:  N Pagnussat; A S Almeida; D M Marques; F Nunes; G C Chenet; P H S Botton; S Mioranzza; C M Loss; R A Cunha; L O Porciúncula
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

4.  [Coffee and mental health].

Authors:  Rafael Franco
Journal:  Aten Primaria       Date:  2009-09-10       Impact factor: 1.137

Review 5.  The neuroprotective effects of caffeine in neurodegenerative diseases.

Authors:  Mahshad Kolahdouzan; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2017-04       Impact factor: 5.243

6.  Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging.

Authors:  Barbara Shukitt-Hale; Marshall G Miller; Yi-Fang Chu; Barbara J Lyle; James A Joseph
Journal:  Age (Dordr)       Date:  2013-01-24

7.  Tea Consumption Reduces the Incidence of Neurocognitive Disorders: Findings from the Singapore Longitudinal Aging Study.

Authors:  L Feng; M-S Chong; W-S Lim; Q Gao; M S Nyunt; T-S Lee; S L Collinson; T Tsoi; E-H Kua; T-P Ng
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

8.  Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.

Authors:  Mahmoud L Soliman; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-15       Impact factor: 4.147

9.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

10.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.